AS
Anchal Srivastava
About Anchal Srivastava
Data last updated:
Anchal Srivastava is a Whole-Time Director at Glalet Pharmaceuticals Private Limited (since 2022), Director at Baya India Industries Private Limited (since 2021) and Whole-Time Director at Baya India Life Care Private Limited (since 2022). The companies operate in Trading, Electrnoics and Home Appliances. The 2 current companies with reported revenue have a combined latest revenue of ₹2.29 Cr; the largest is Glalet Pharmaceuticals Private Limited at ₹2.10 Cr (FY 2024). Earlier, Anchal Srivastava was a Director at R S G Sales & Services Private Limited (2021–2022) and Director at Aps Info Solutions Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glalet Pharmaceuticals Private Limited U51909UP2022PTC166358 | Whole-Time Director | 24 Jun 2022 | 2022 | ₹2.10 Cr (FY 2024) | Active |
| Baya India Industries Private Limited U31900UP2021PTC140055 | Director | 07 Jan 2021 | 2021 | ₹18.7 Lakh (FY 2025) | Active |
| Baya India Life Care Private Limited U51397UP2022PTC165594 | Whole-Time Director | 13 Jun 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 R S G Sales & Services Private Limited U31100UP2013PTC061000 | Director | 10 Jun 2021 | 2013 | ₹1.80 Cr (FY 2025) | Active |
 Aps Info Solutions Private Limited U74120UP2013PTC057477 | Director | 06 Jun 2013 | 2013 | ₹1.9 Lakh (FY 2018) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anchal Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prashant Sen Srivastava | 09650403 | Glalet Pharmaceuticals Private Limited | Whole-Time Director |
| Himani Srivastava | 09021378 | Baya India Industries Private Limited | Director |
| Adamya Aggarwal | 02014285 | Baya India Life Care Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anchal Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anchal Srivastava
Anchal Srivastava currently holds 3 directorships: Glalet Pharmaceuticals Private Limited (Whole-Time Director, since 24 Jun 2022, revenue ₹2.10 Cr (FY 2024)); Baya India Industries Private Limited (Director, since 07 Jan 2021, revenue ₹18.7 Lakh (FY 2025)); Baya India Life Care Private Limited (Whole-Time Director, since 13 Jun 2022).
Anchal Srivastava was first appointed on 06 Jun 2013 as Director at Aps Info Solutions Private Limited. The most recent appointment on record is 24 Jun 2022 at Glalet Pharmaceuticals Private Limited.
The 2 current companies of Anchal Srivastava that report revenue have a combined latest revenue of ₹2.29 Cr: Glalet Pharmaceuticals Private Limited ₹2.10 Cr (FY 2024); Baya India Industries Private Limited ₹18.7 Lakh (FY 2025).
Anchal Srivastava held 2 earlier board appointments: R S G Sales & Services Private Limited (Director, 10 Jun 2021 to 24 Aug 2022); Aps Info Solutions Private Limited (Director, from 06 Jun 2013).
The current boards of Anchal Srivastava's companies include Prashant Sen Srivastava (Glalet Pharmaceuticals Private Limited), Himani Srivastava (Baya India Industries Private Limited), Adamya Aggarwal (Baya India Life Care Private Limited).